T1	Participants 61 84	Cancer Prevention Trial
T2	Participants 137 183	breast cancer prevention study ever undertaken
T3	Participants 288 374	to demonstrate whether a drug, tamoxifen, can prevent breast cancer in high-risk women
T4	Participants 422 625	whether tamoxifen is effective in 1) reducing the incidence of invasive breast cancer, 2) reducing breast cancer mortality, 3) reducing deaths from cardiovascular disease, and 4) reducing bone fractures.
